Document is current

Any future updates will be listed below

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Crossref DOI link: https://doi.org/10.1007/s12325-019-00994-7

Published Online: 2019-06-20

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark